These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25537684)

  • 1. 'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models.
    Vauquelin G; Hall D; Charlton SJ
    Br J Pharmacol; 2015 May; 172(9):2300-15. PubMed ID: 25537684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of direct competition and allosteric modulation of small-molecular-weight protein ligands using surface plasmon resonance methods.
    Huber W; Sinopoli A; Kohler J; Hug M; Ruf A; Huber S
    J Mol Recognit; 2015 Aug; 28(8):480-91. PubMed ID: 25763559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands.
    Vauquelin G; Charlton SJ
    Br J Pharmacol; 2013 Apr; 168(8):1771-85. PubMed ID: 23330947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt.
    de Vries RMJM; Meijer FA; Doveston RG; Leijten-van de Gevel IA; Brunsveld L
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.
    Jakubík J; Randáková A; El-Fakahany EE; Doležal V
    PLoS One; 2019; 14(3):e0214255. PubMed ID: 30917186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor.
    Guo D; Venhorst SN; Massink A; van Veldhoven JP; Vauquelin G; IJzerman AP; Heitman LH
    Br J Pharmacol; 2014 Dec; 171(23):5295-312. PubMed ID: 25040887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric small molecule modulators of nuclear receptors.
    Meijer FA; Leijten-van de Gevel IA; de Vries RMJM; Brunsveld L
    Mol Cell Endocrinol; 2019 Apr; 485():20-34. PubMed ID: 30703487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPCR drug discovery through the exploitation of allosteric drug binding sites.
    Rees S; Morrow D; Kenakin T
    Recept Channels; 2002; 8(5-6):261-8. PubMed ID: 12690954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric Binding Sites On Nuclear Receptors: Focus On Drug Efficacy and Selectivity.
    Fischer A; Smieško M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography of binding.
    Kenakin TP
    Mol Pharmacol; 2008 Sep; 74(3):541-3. PubMed ID: 18583453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for positive allosteric modulators: assessment of modulator concentration-response curves as a screening paradigm.
    Langmead CJ
    J Biomol Screen; 2007 Aug; 12(5):668-76. PubMed ID: 17478477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Allosteric Effects from Orthosteric Binding in Hsp90-Ligand Interactions: Implications for Fragment-Based Drug Design.
    Chandramohan A; Krishnamurthy S; Larsson A; Nordlund P; Jansson A; Anand GS
    PLoS Comput Biol; 2016 Jun; 12(6):e1004840. PubMed ID: 27253209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions.
    Avlani VA; McLoughlin DJ; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2008 Jun; 325(3):927-34. PubMed ID: 18322151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of rigid or flexible linkage between two ligands on the effective affinity and avidity for reversible interactions with bivalent receptors.
    Bobrovnik SA
    J Mol Recognit; 2007; 20(4):253-62. PubMed ID: 17847051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric mechanisms of nuclear receptors: insights from computational simulations.
    Mackinnon JA; Gallastegui N; Osguthorpe DJ; Hagler AT; Estébanez-Perpiñá E
    Mol Cell Endocrinol; 2014 Aug; 393(1-2):75-82. PubMed ID: 24911885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-canonical modulators of nuclear receptors.
    Tice CM; Zheng YJ
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4157-64. PubMed ID: 27503683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.